HK1 and hepatocellular carcinoma: To test this hypothesis, we first measured the expression of glucose transporters and key glycolytic enzymes after knockdown of ETV4 in two human hepatocellular carcinoma cell lines HepG2 and Huh7, which show high glycolytic activities39.